{
    "nctId": "NCT03117894",
    "briefTitle": "PECS-2 for Breast Surgery",
    "officialTitle": "Regional Anesthesia for Breast Cancer Surgery, Effects on Postoperative Wellbeing and Disease Recurrence.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasm Female, Regional Anesthesia, Anesthesia, Regional Anesthesia Morbidity, Anesthesia Morbidity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Opiate consumption",
    "eligibilityCriteria": "Inclusion Criteria: Unilateral surgery on the breast because of suspected malign disease.\n\nExclusion Criteria:\n\nBilateral surgery\n\nMetastases other than in the axilla\n\nBody Mass Index (BMI) \\> 35\n\nNot able to communicate in Swedish\n\nDementia\n\nAmerican Society of Anesthesiology (ASA) 4 or 5\n\nChronic pain treatment (use of opiates or medicine for neuropathic pain \\> 7 days the last month)\n\nKnown allergy to Morphine or Ropivacaine\n\nCongestive Heart Failure, New York Heart Association (NYHA) IIIB or worse\n\nChronic renal failure (S-creatinine increased)\n\nImmunosuppression (more than 10 mg daily of Prednisolone or stronger medication)\n\nNo axillary exploration planned",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}